We are live on ! Find out more
JSPR icon

Jasper Therapeutics
JSPR

10 hedge funds and large institutions have $102M invested in Jasper Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $82.2M → $102M (+$20M)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

82% less funds holding

Funds holding: 57 → 10 (-47)

89% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 53

Holders
10
Holders Change
-47
Holders Change %
-82.46%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
2
Reduced
2
Closed
53
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
A
Abingworth
United Kingdom
+$57.5M
2
Citadel Advisors
Citadel Advisors
Florida
+$29.8M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$15.3M
4
Morgan Stanley
Morgan Stanley
New York
+$1.11M
5
Jane Street
Jane Street
New York
+$266K

Top Sellers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
-$6.49M
2
TCM
Tenor Capital Management
New York
-$4.97M
3
FTCM
Fir Tree Capital Management
New York
-$4.83M
4
SCM
Shaolin Capital Management
Florida
-$4.46M
5
WRBC
W.R. Berkley Corp
Connecticut
-$4.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
A
1
Abingworth
United Kingdom
$58M +$57.5M +562,856 New
Citadel Advisors
2
Citadel Advisors
Florida
$29.2M +$29.8M +291,870 +3,380%
Federated Hermes
3
Federated Hermes
Pennsylvania
$12.5M +$15.3M +150,000 New
Morgan Stanley
4
Morgan Stanley
New York
$1.12M +$1.11M +10,886 New
LPARFS
5
Leverage Partners Absolute Return Fund SPC
Cayman Islands
$815K +$153K +1,500 New
Jane Street
6
Jane Street
New York
$267K +$266K +2,603 New
Tudor Investment Corp
7
Tudor Investment Corp
Connecticut
$205K +$204K +2,000 New
TRCT
8
Tower Research Capital (TRC)
New York
$92K +$90.9K +890 +17,800%
UBS Group
9
UBS Group
Switzerland
$6K -$12.6K -123 -69%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$2K -$19.3K -189 -90%
MSU
11
Mizuho Securities USA
New York
– -$6.49M -65,513 Closed
TCM
12
Tenor Capital Management
New York
– -$4.97M -50,000 Closed
FTCM
13
Fir Tree Capital Management
New York
– -$4.83M -48,492 Closed
SCM
14
Shaolin Capital Management
Florida
– -$4.46M -44,820 Closed
WRBC
15
W.R. Berkley Corp
Connecticut
– -$4.35M -43,786 Closed
KIM
16
Karpus Investment Management
New York
– -$4.28M -43,076 Closed
RCM
17
Radcliffe Capital Management
Pennsylvania
– -$4.04M -40,680 Closed
KKRC
18
Kohlberg Kravis Roberts & Co
New York
– -$3.7M -37,265 Closed
DCM
19
Dupont Capital Management
Delaware
– -$2.98M -30,000 Closed
BCM
20
Basso Capital Management
Connecticut
– -$2.84M -28,538 Closed
Goldman Sachs
21
Goldman Sachs
New York
– -$2.82M -28,397 Closed
BI
22
Bulldog Investors
New Jersey
– -$2.76M -27,797 Closed
MP
23
Mangrove Partners
Connecticut
– -$2.7M -27,146 Closed
KPF
24
K2 Principal Fund
Ontario, Canada
– -$2.46M -24,746 Closed
PAMP
25
Polar Asset Management Partners
Ontario, Canada
– -$1.93M -19,374 Closed
1
2 3

JSPR Hedge Fund Activity: Q3 2021 in Review

10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q3 2021, worth a combined $102M — up 24% from $82.2M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of JSPR and 6 opened new positions — a net loss of 47 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Abingworth, opening a new position worth an estimated $57.5M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $6.49M sold.

  • 10 institutional investors held Jasper Therapeutics (JSPR) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $102M of Jasper Therapeutics stock for Q3 2021, up 24% quarter-over-quarter.
  • 6 funds opened new Jasper Therapeutics positions in Q3 2021 and 53 closed out, a net change of -47 holders.
  • The largest Jasper Therapeutics buyer in Q3 2021 was Abingworth, an estimated $57.5M added.
  • The largest Jasper Therapeutics seller in Q3 2021 was Mizuho Securities USA, an estimated $6.49M sold.

Based on aggregated 13F filings for Q3 2021.